Legal status · United States
Is ARD-101 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. ARD-101 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 4 human studies are cited on its profile.
ARD-101 in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Both phase 3 trials in Prader-Willi syndrome are terminated. Not approved and not available. |
| FDA approval status | Never approved. Both phase 3 trials in Prader-Willi syndrome carry status TERMINATED on ClinicalTrials.gov. |
| Human studies cited | 4 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the ARD-101 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing ARD-101 is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What ARD-101 is
It reduced hunger in adults by activating bitter taste receptors in the gut, and both of its phase 3 trials in Prader-Willi syndrome were terminated.
Bitter taste receptors are not confined to the tongue. They line the gastrointestinal tract, where activating them triggers release of gut hormones including GLP-1 and cholecystokinin.
Mechanism: An orally administered agonist at type 2 taste receptors, TAS2Rs, engineered to remain within the gastrointestinal lumen rather than being absorbed. TAS2Rs are expressed on enteroendocrine cells throughout the gut, and activating them stimulates secretion of endogenous satiety hormones including glucagon-like peptide-1, cholecystokinin and peptide YY.
Regulatory history: Never approved. Both phase 3 trials in Prader-Willi syndrome carry status TERMINATED on ClinicalTrials.gov.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for ARD-101 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
ARD-101 in other countries
Frequently asked questions
Is ARD-101 legal in the United States?
No. ARD-101 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 4 human studies are cited on its profile. Note: Both phase 3 trials in Prader-Willi syndrome are terminated. Not approved and not available.
Can I buy ARD-101 in the United States?
No approved product exists to buy. In the United States ARD-101 is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Both phase 3 trials in Prader-Willi syndrome are terminated. Not approved and not available.
Is ARD-101 FDA approved?
No. FDA status: Never approved. Both phase 3 trials in Prader-Willi syndrome carry status TERMINATED on ClinicalTrials.gov.. Current US classification: "Not approved; research use only". On the evidence, 4 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for ARD-101 live on its compound profile.
ARD-101 profileThis page is general information about the regulatory status of ARD-101 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.